NIH Seeks Exclusive License for Dengue Vaccine Patent

Summary

The National Institutes of Health (NIH) is issuing a notice of intent to grant an exclusive license to practice a purified inactivated dengue tetravalent vaccine, which has undergone significant development and testing, including patent applications filed in multiple countries and approved by the U.S. Patent and Trademark Office.